Currently, the modulation of intestinal microbiota through microecological therapies, including probiotics, prebiotics, and fecal microbiota transplantation, is a prominent area of clinical investigation for preventing and managing hyperuricemia and gout
Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
Vic b sung L-carnitine trn 4g/ngy s lm tng nng trimethylamine-N-oxide (TMAO) trong mu theo thi gian
Can I continue GLP-1 therapy if I develop gallstones
It should be used together with a reduced-calorie diet and increased physical activity
Integration of Digital Health and Personalized Medicine Programs Modern GLP-1 drug suppliers are incorporating digital health technologies, personalized dosing systems, and patient monitoring platforms to enhance therapeutic outcomes, improve patient adherence, and meet healthcare demands for intelligent and connected diabetes management solutions